Prostate Cancer - Results from #25160

A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer - Abstract May 2, 2011

Comorbidity and competing risks for mortality in men with prostate cancer - Abstract May 2, 2011

Prostate cancer stem cells and their potential roles in metastasis - Abstract May 2, 2011

A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study - Abstract May 2, 2011

Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins - Abstract May 2, 2011

Contemporary management of postprostatectomy incontinence - Abstract May 2, 2011

EAU 2011 - Antibiotics and/or alpha blocker agents may decrease the PSA levels before biopsy but not detection rate of prostate cancer - Session Highlights May 2, 2011

EAU 2011 - Metabolic syndrome and prostate cancer: A possible link to prostate cancer aggressiveness - Session Highlights May 2, 2011

EAU 2011 - Periprostatic fat pads harbor lymph nodes and lymph node metastases: Impact on pathological work up - Session Highlights May 1, 2011

PROVENGE (sipuleucel-T) in prostate cancer: The first FDA approved therapeutic cancer vaccine - Abstract April 29, 2011

Drug development for metastatic castration-resistant prostate cancer: Current status and future perspectives - Abstract April 29, 2011

Emerging novel therapies in the treatment of castrate-resistant prostate cancer - Abstract April 29, 2011

The impact of clinical factors on the development of late radiation toxicity: Results from the Medical Research Council RT01 Trial (ISRCTN47772397) - Abstract April 29, 2011

Biochemical-markers for the diagnosis of bone metastasis: A review in clinical - Abstract April 29, 2011

Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscape - Abstract April 29, 2011

Barriers and facilitators to digital rectal examination screening among African-American and African-Caribbean men - Abstract April 29, 2011

Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy - Abstract April 29, 2011

FDA approves Zytiga for late-stage prostate cancer April 29, 2011

EAU 2011 - Nation-wide population-based study on 15-year mortality in prostate cancer according to risk categories in the National Prostate Cancer Register (NPCR) of Sweden - Session Highlights April 29, 2011

Listening to Provenge - what a costly cancer treatment says about future Medicare policy - Abstract April 28, 2011

Page 1259 of 1288